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A B S T R A C T
The blockage of the de novo pyrimidine biosynthetic pathway at the orotidine-5′-phosphate decarboxylase level
was previously demonstrated to affect riboflavin production in the industrial producer fungus Ashbya gossypii.
However, the molecular basis for the unusual sensitivity to uracil displayed by the pyrimidine auxotroph A.
gossypii Agura3 was unknown. Here, uridine was shown to be the only intermediate of the pyrimidine salvage
pathway able to fully restore this mutant’s growth. Conversely, uracil, which is routinely used to rescue pyr-
imidine auxotrophs, had a dose-dependent growth-inhibitory effect. Uracil phosphoribosyltransferase (UPRT) is
the pyrimidine salvage pathway enzyme responsible for converting uracil to uridine monophosphate in the
presence of phosphoribosyl pyrophosphate (PRPP). Characterization of the A. gossypii UPRT, as produced and
purified from Escherichia coli, revealed that uracil concentrations above 1mM negatively affected its activity,
thus explaining the hypersensitivity of the Agura3 mutant to uracil. Accordingly, overexpression of the AgUPRT
encoding-gene in A. gossypii Agura3 led to similar growth on rich medium containing 5mM uracil or uridine.
Decreased UPRT activity ultimately favors the preservation of PRPP, which otherwise may be directed to other
pathways. In A. gossypii, increased PRPP availability promotes overproduction of riboflavin. Thus, this UPRT
modulation mechanism reveals a putative means of saving precursors essential for riboflavin overproduction by
this fungus. A similar uracil-mediated regulation mechanism of the UPRT activity is reported only in two pro-
tozoan parasites, whose survival depends on the availability of PRPP. Physiological evidence here discussed
indicate that it may be extended to other distantly related flavinogenic fungi.
Introduction
The use of auxotrophies as tools for genetic modification of micro-
bial strains is widely employed in molecular microbiology. However,
there are some recognized problems associated with their use, such as a
lack of clarity regarding how much nutrient supplementation is re-
quired for each auxotrophy and microorganism [1,2]. Auxotrophy for
pyrimidines, resulting from blockage of the de novo pyrimidine bio-
synthetic pathway at the orotidine 5′-phosphate decarboxylase level
(encoded by URA3 or corresponding ortholog in non-yeast species) or at
the orotate phosphoribosyltransferase level (encoded by URA5 or
homologs), is one of the most used among microbes [1–3]. As standard
procedure, these mutants require the supply of exogenous uracil to
rescue their growth, thus being termed uracil auxotrophs.
Uracil enters the pyrimidine salvage pathway and is converted to
uridine monophosphate (UMP) in a one-step reaction catalyzed by ur-
acil phosphoribosyltransferase (UPRT), thus re-establishing the bio-
synthesis of pyrimidines (Fig. 1). While efficient in restoring growth of
the majority of the pyrimidine auxotrophs, the supply of exogenous
uracil is unable to fully overcome the effects of this auxotrophy in some
fungi, which require the supply of exogenous uridine. Among them are
Candida albicans [3], Ashbya gossypii (syn. Eremothecium gossypii) [4],
Debaryomyces hansenii (syn. Candida famata) [5], Candida guilliermondii
(syn. Pichia guilliermondii) [6], Aspergillus fumigatus [7] and Aspergillus
nidulans [8]. Despite the importance of this apparently uncommon
phenotype, it is poorly understood at the molecular level.
A. gossypii is a filamentous fungus of considerable industrial and
biological significance, due to its capacity to overproduce riboflavin
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(vitamin B2) and to its unique genetic and biological features [9,10].
The genetic blockage of its pyrimidine pathway at the AgURA3 level
(orotidine 5’-P to UMP) leads to increased riboflavin production on
standard Ashbya Full Medium (AFM), a phenotype that is reverted
when extra uridine/uracil (≥0.5/1mM) is added to the medium [11].
Unlike ura3 mutants from the closely related yeasts Saccharomyces
cerevisiae and Kluyveromyces sp. [12], the A. gossypii Agura3 mutant not
only requires the supply of exogenous uridine to fully overcome its
auxotrophy, but its growth is also inhibited by high uracil concentra-
tions [4,11]. Thus, the ura3 mutation, a common genetic alteration
among microorganisms, has a profound impact not only on the growth
but also on the physiology of this fungus.
In order to elucidate the molecular mechanism(s) underlying the
unusual phenotypes of this A. gossypii pyrimidine auxotroph, here its
growth was analyzed on media containing different pyrimidine sup-
plements, envisioning the detection of bottlenecks in the pyrimidine
salvage pathway. This allowed the identification of limitations at the
AgUPRT level (Fig. 1). Characterization of recombinant AgUPRT re-
vealed a type of metabolic enzyme regulation previously unknown in A.
gossypii. Moreover, common features with other organisms, such as
unrelated protozoan parasites [13,14] and other flavinogenic fungi,
were identified and discussed, thus extending the impact of this study.
Materials and methods
Strains and media
The A. gossypii Agura3 strain (Agura3Δ::loxP) [4], a uridine/uracil
auxotroph derived from the parental strain A. gossypii ATCC 10895, was
used in this study. For AgFUR1 overexpression, the AFR052C ORF
(NCBI Reference Sequence: NM_210953.1) was isolated from the A.
gossypii genome by PCR (5’cggaattcATGaaaagttttagtgcccg and
5’ccgctcgagTCAtatgcagtagtaccgg) and cloned between the EcoRI and
XhoI restriction sites of the plasmid pFMT [15], under the regulation of
the strong constitutive promoter AgTEF. The resulting plasmid
(pFMTAgFUR1) was then transformed into the Agura3 strain as pre-
viously described [15]. Stock cultures of these strains were maintained
as spores suspended in Spore Buffer (200 g L−1 glycerol, 8 g L −1 NaCl
and 0.25% (v v-1) Tween 20) at −80 °C. Spores were prepared as pre-
viously described [15] with minor modifications. The mycelium was
digested with 4mgmL-1 of Lysing Enzymes from Trichoderma harzanium
(Sigma-Aldrich) for 2 h at 37 °C. Agar-solidified minimal medium (MM;
6.7 g L-1 yeast nitrogen base, 20 g L-1 glucose and 1 g L-1 CaCO3), syn-
thetic complete (SC) medium [16] (without uracil) buffered with 1 g L-1
CaCO3 and AFM (10 g L-1 tryptone, 10 g L-1 yeast extract, 20 g L-1 glu-
cose, 1 g L-1 myo-inositol) were used for the growth of A. gossypii
strains. Where indicated, 200 μgmL-1 geneticin (G418) was added to
the medium for plasmid maintenance. Escherichia coli NZY5α and
NZYBL21 (DE3) (NZYTech) were used for plasmid construction and
recombinant protein production, respectively. E. coli strains were
grown in LB medium (5 g L-1 yeast extract, 10 g L-1 tryptone, 10 g L-1
NaCl) supplemented with 100 μgmL-1 ampicillin for selection.
Radial growth conditions for A. gossypii strains
Agar-solidified MM, SC or AFM supplemented with uracil, uridine,
cytosine or cytidine at 0, 1, 4 or 5mM was inoculated with 10 μL of a
suspension of spores (107 spores mL−1) and incubated at 30 °C for 8
days. Colony radial growth [17] was determined daily by measuring the
diameter of colonies in 90mm diameter Petri dishes in two perpendi-
cular directions, through two guide lines previously drawn on the lower
outer face of the plates. Three biological replicas were used for each
condition. Images of the colony morphology were recorded using a
Molecular Imager ChemiDoc™ XRS+ Imaging System (Bio-Rad) with the
Image Lab 4.0 software at day 8 of growth. The lag phase corresponded
to the time (in days) that no growth was observed beyond the inoculum
halo. The maximum radial growth rate was obtained through the slope of
the trend line of a linear regression applied to the radial growth curve
Fig. 1. Schematic representation indicating the de novo and salvage pathways of pyrimidine ribonucleotides. Red×marks where the de novo pyrimidine biosynthetic
pathway is blocked in the A. gossypii Agura3 uracil auxotroph. Dashed arrows indicate a multi-step pathway. UMP: uridine monophosphate. Numbers indicate the
enzymes involved in each step of the pyrimidine pathways. 1: nucleosidase/uridine nucleosidase; 2: cytidine deaminase; 3: cytosine deaminase; 4: uridine kinase; 5:
uracil phosphoribosyltransferase; 6: orotate phosphoribosyltransferase; 7: orotidine-5’-phospate decarboxylase.
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excluding the lag phase. The percentage of relative growth was de-
termined by normalizing the maximum radial growth of each condition
by the maximum radial growth obtained with 5mM uridine.
AgUPRT sequence analysis, recombinant production and purification
Multiple protein sequence alignment was performed with Clustal
Omega [18] (https://www.ebi.ac.uk/Tools/msa/clustalo/) using de-
fault parameters and FigTree v1.4.3 (http://tree.bio.ed.ac.uk/software/
figtree/) was used to visualize the phylogenetic tree produced by
Clustal Omega. Amino acid sequences were retrieved from NCBI (Na-
tional Center for Biotechnology Information; https://www.ncbi.nlm.
nih.gov/). The full-length AgFUR1 cDNA, with codons optimized for
recombinant expression in E. coli and flanked by NcoI and XhoI re-
cognition sites at the 5’- and 3’-end, respectively, was synthesized by
NZYTech (Lisbon, Portugal). The AgFUR1 synthetic gene was excised
from the carrying plasmid by digestion with NcoI and XhoI and ligated
to the pETM20 vector (EMBL) in fusion with the N-terminal thioredoxin
A (TrxA) and His6 tags (linked to the cloning site by a TEV protease
recognition sequence) [19], and the construct was transformed into
chemically competent NZY5α E. coli cells (NZYTech). The AgUPRT
expression plasmid (pETMAgFUR1) was then transformed into the E.
coli expression strain NZYBL21 (DE3) (NZYTech). A transformant
colony was picked and grown in 100mL of LB medium containing
100 μg/mL ampicillin to an OD600nm of 0.5, and protein expression was
induced with 0.2mM IPTG for 16 h at 18 °C. Cells were recovered by
centrifugation (at 4 °C for 15min at 10,000 rpm) from 20mL culture
fractions and lysed with NZY Bacterial Cell Lysis Buffer (NZYTech)
supplemented with 1mM PMSF, according to the manufacturer’s in-
structions. Soluble cell-free extracts were collected by centrifugation
and incubated with 0.5mL of HisPur™ Ni-NTA Resin (Thermo Fisher
Scientific) for purification of the recombinant fusion protein. Purifica-
tion was conducted according to the manufacturer’s instructions as
given for the batch method, using 50mM Tris pH 8.0, 150mM NaCl
(Tris-NaCl buffer) with 20mM imidazole as equilibration buffer, and
Tris-NaCl buffer with 40mM or 300mM imidazole as washing and
elution buffer, respectively. For TrxA-His6 partner removal, the purified
fusion protein was digested with TEV-His6 protease overnight at 4 °C at
the ratio of 1:20 (w w−1) in equilibration buffer. Elution buffer was
previously exchanged with equilibration buffer using a PD MidiTrap G-
25 column (GE Healthcare). The cleaved AgUPRT was then purified
from the fusion tags and protease by reverse purification using the same
resin and above-mentioned protocol, but in which the target protein
was collected from the resin washing steps. Purified protein was ana-
lyzed by SDS-PAGE using 15% (w v−1) acrylamide gels, followed by
BlueSafe staining (NZYTech). Predicted size for cleaved AgUPRT was
26.3 kDa. Imidazole was removed from the protein using the PD
MidiTrap G-25 column (GE Healthcare). The concentration of re-
combinant AgUPRT was estimated from the absorbance at 280 nm
using the respective molar extinction coefficient (ε=13,785
M−1 cm−1). Purified AgUPRT was stored at 4 °C until use.
Enzyme activity assays
AgUPRT enzyme activity was determined spectrophotometrically by
measuring the conversion of uracil into UMP as previously described
[14,20]. To determine the effect of uracil concentration on AgUPRT
activity, the assay mixture consisted of TMD 50 buffer (50mM
Tris−HCl, 5mM MgCl2, and 2mM DTT, pH 7.5) with 1mM phosphor-
ibosyl pyrophosphate (PRPP) and uracil concentrations ranging from
10 μM to 1.25mM. To assess the influence of different PRPP concentra-
tions on AgUPRT activity, the assay mixture consisted of TMD 50 buffer
with 0.5mM uracil, and PRPP concentrations ranging from 25 μM to
2mM. For each condition tested and prior to the assay, the background
absorbance was set to zero to remove any response caused by substrates
or reagents. Enzyme activity measurements were performed using a V-
560 UV/Vis Spectrophotometer (Jasco) at 30 °C, and reactions were in-
itiated by the addition of approximately 2 μg of enzyme to the assay
mixture (1mL final volume in a 1 cm quartz cuvette). The assays were
based on the differential molar absorption coefficients between uracil
and UMP at 280 nm (Δє=1407.5 M−1 cm−1). An increase in absor-
bance was observed due to the formation of UMP, which was monitored
for up to 2min. Initial rates were calculated from the linear part of each
reaction progress curve, converted to specific enzyme activity (μmol
min−1 mgprotein−1) and then plotted against substrate concentration.
Statistical analysis
GraphPad Prism for IOS version 6.0 was used for all statistical
analyses. Differences between A. gossypii´s growths were tested by two-
way ANOVA followed by Tukey’s multiple comparison test. The ana-
lysis of differential AgUPRT activity was conducted by one-way ANOVA
followed by Dunnett´s multiple comparison test. Statistical significance
was established at p < 0.05 for the comparisons.
Results and discussion
The growth of A. gossypii Agura3 can only be fully restored by the
Table 1
Maximum radial growth rates and lag phases of A. gossypii Agura3 on agar-
solidified MM supplemented with different concentrations of intermediates
from the pyrimidine salvage pathway. Data are representative of three biolo-
gical replicates. Radial growth rates are expressed as mean ± standard de-
viation. Superscripts represent significant differences (p< 0.05) between va-
lues of the same column (supplement concentration). n.d., not determined,
because for this condition growth was only observed in the last day (day 8),
which impeded determination of the maximum radial growth rate; –, no growth
beyond the inoculum halo.
Maximum radial growth rate
(mm day−1)
Lag phase
(days)
1 mM 4 mM 5mM 1mM 4 mM 5mM
Uridine 10.9 ± 1.4a 10.8 ± 0.3a 12.9 ± 0.1a 3 2 2
Uracil 5.6 ± 0.2b 2.9 ± 0.1d n.d. 3 3 7
Cytosine – 4.2 ± 0.3c 6.5 ± 0.5b – 5 4
Cytidine 6.9 ± 0.7b 6.4 ± 0.6b 6.5 ± 0.6b 5 3 3 Fig. 2. Maximum relative growth of A. gossypii Agura3 on agar-solidified MM
supplemented with different concentrations of intermediates from the pyr-
imidine salvage pathway. The percentage of maximum relative growth was
normalized to the radial growth of the best condition tested (5mM uridine).
Data are representative of three biological replicas after 8 days of growth.
Letters represent significant differences (p < 0.05) between bars with the same
supplement concentration.
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addition of uridine to the medium [4], being inhibited by high uracil
concentrations [11]. A similar phenotype has been reported for uracil
auxotrophs of A. nidulans [8]. Although not experimentally demon-
strated, the growth-inhibitory effect of high uracil concentrations ob-
served in A. nidulans pyrimidine auxotrophs was proposed to be linked
with misincorporation of uracil into the DNA. This seems not to be the
case for A. gossypii, since the parental strain of Agura3 (ATCC 10895)
did not display deficient growth when grown at high concentrations of
uracil (Supplementary Figure A1) and no evidence was found for
genomic DNA damage under these conditions using different DNA
electrophoretic techniques (data not shown). Therefore, per se, the
presence in the medium of a high content of the pyrimidine supplement
is not deleterious for growth of this fungus, becoming detrimental only
when uracil metabolism is required. Thus, this study focused on the
characterization of the A. gossypii pyrimidine salvage pathway which
according to the available genomic information (the Ashbya Genome
Database) [21] has two independent routes by which UMP can be
synthesized, one via AgUPRT and the other via uridine kinase, which
converts uridine directly into UMP (Fig. 1).
Growth-rescuing effect of various pyrimidine supplements on A. gossypii
Agura3
In an attempt to identify potential rate-limiting steps in the A. gos-
sypii pyrimidine salvage pathway, the colony radial growth of A. gos-
sypii Agura3 was characterized on agar-solidified minimal medium
(MM) supplemented with different concentrations (1, 4 or 5mM) of one
of the four intermediates in the pyrimidine salvage pathway, namely
uracil, uridine, cytosine or cytidine (Table 1; Fig. 2). This range of
concentrations was chosen based on previous results showing that this
strain’s growth is highly hampered by uracil concentrations ≥5mM
and minimally affected by ≤1mM uracil [11]. In addition to MM, two
other media with distinct basal composition, one defined (SC) and one
rich (AFM), were also supplemented with 5mM uracil, uridine or cy-
tosine and used to test the growth of A. gossypii Agura3 (Fig. 3A and B).
Uracil is usually supplied at concentrations below 5mM to rescue the
growth of uracil auxothrophs of other fungi. Thus, to confirm that the
growth-inhibitory effect of uracil is not common among fungal pyr-
imidine auxotrophs, we tested the growth of the frequently used S.
cerevisiae CEN.PK113-5D (ura3-), Yarrowia lipolytica Po1f (leu- ura- Δaep
Δaxp SUC+) and K. marxianus KMS2 (ura3-) in SC and verified that
their growth was not affected by up to 10mM uracil in the medium
(Supplementary Figure A2).
Regardless of the medium and supplement concentration, uridine
always performed the best in rescuing the growth of the A. gossypii
Agura3 mutant (Table 1; Figs. 2, 3 A, 3B). In MM, even with the lowest
concentration tested (1mM), the radial growth of Agura3 on uridine
was superior to that obtained with 5mM of any other pyrimidine
supplement (Table 1; Fig. 2). Uridine supplementation also produced
the shortest lag phases (Table 1; Fig. 3A). In contrast, uracil failed to
completely rescue the growth of the Agura3 mutant. Moreover, in-
creasing concentrations of this supplement were increasingly
Fig. 3. Radial growth curves and colony morphologies of A. gossypii Agura3 on agar-solidified SC (A) or AFM (B) supplemented with 5mM uridine, uracil or cytosine.
(C) Maximum relative growth and colony morphology of A. gossypii Agura3 overexpressing the gene AgFUR1 on agar-solidified AFM supplemented with 5mM uridine
or uracil. Letters represent significant differences (p < 0.05) between bars (supplementation). The control conditions represent media without added supplement.
The growth observed in AFM without any added supplement is due to the presence of small quantities of various pyrimidines in the complex constituents of this rich
medium. Data represent the average± standard deviation from three (A and B) or two (C) biological replicates. (Where not shown, error bars were smaller than the
symbols). Images were recorded after 8 days of growth.
R. Silva et al. New BIOTECHNOLOGY 50 (2019) 1–8
4
detrimental for the growth of this auxotroph (Table 1; Fig. 2, 3 A).
Cytosine, which is metabolized into uracil before conversion to UMP
through the AgUPRT route (Fig. 1), was also unable to fully restore
growth (Figs. 2,3), but a positive correlation was observed between
cytosine concentration and growth (Table 1; Fig. 2). On the other hand,
cytidine, which can be metabolized into UMP via UPRT or uridine ki-
nase (Fig. 1), exceeded uracil and cytosine, but not uridine, in rescuing
growth (Table 1; Fig. 2). Morphologically, the colonies grown on media
supplemented with uracil or cytosine presented an irregular shape,
contrasting with the normal circular shape displayed on uridine-sup-
plemented media (Fig. 3A, B). In addition, wrinkled colonies were ob-
served on rich AFM supplemented with uracil or cytosine, whereas
smooth flat colonies were found in plates with uridine (Fig. 3B).
Uridine can be directly metabolized by A. gossypii into UMP without
going through the AgUPRT route. Thus, altogether, these results iden-
tified the AgUPRT-catalyzed reaction as the likely rate-limiting step in
the A. gossypii pyrimidine salvage pathway responsible for the dose-
dependent detrimental effect of uracil on the growth of Agura3. Indeed,
overexpression of the AgUPRT encoding-gene in Agura3 led to im-
proved growth on AFM containing 5mM uracil, to an extent that the
maximum radial growth obtained with uracil was no longer statistically
different from that obtained with the same amount of uridine (Fig. 3C).
AgUPRT sequence analysis, recombinant production and purification
AgUPRT is a 232 amino acids-long protein encoded by the gene
AFR052C (syntenic homolog of S. cerevisiae gene FUR1) (Fig. 4A).
Highly conserved regions across UPRTs from organisms of different
kingdoms and even superkingdoms [22] are also conserved in AgUPRT
(shaded gray in Fig. 4A). The AgUPRT amino acid sequence shares high
identity (˜ 80%) with the UPRTs from closely related yeasts, such as S.
cerevisiae and K. marxianus, and 53% with the well-characterized UPRTs
from the distantly related protozoan parasites Leishmania donovani and
Toxoplasma gondii (Fig. 4B). Curiously, despite belonging to closely
related parasites, the UPRTs from L. donovani and T. gondii share less
identity between each other (49%) than with that of A. gossypii
(Fig. 4B).
Important secondary structures described for the T. gondii UPRT, as
well as the binding regions for its substrates, PRPP and uracil [23], are
indicated in Fig. 4A. While the PRPP and uracil binding regions are
highly conserved across species, the β-arm and the flex-loop zones only
share a degree of conservation across closely related species (Fig. 4A).
In C. albicans, resistance to 5-flucytosine (5-FC) was associated with
decreased UPRT activity due to the substitution of the arginine residue
corresponding to R126 in AgUPRT by cysteine (C) [24]. None of the 8
UPRTs aligned here have a cysteine in that position, the arginine re-
sidue being conserved among 7 of them (Fig. 4A). 5-FC is an antifungal
prodrug that is metabolized by cytosine deaminase into 5-fluorouracil
(5-FU), which relies on its catalysis by UPRT to exert toxicity [24,25].
In Leishmania infantum, substitution of the lysine corresponding to K139
in AgUPRT by a threonine (T) was found to contribute to increased
resistance to 5-FU [25]. This lysine is also conserved among the UPRTs
aligned in Fig. 4A.
Since the in silico analysis of the AgUPRT did not highlight any
particular feature that could account for limitations in its enzymatic
activity, experimental characterization of this enzyme was carried out.
The AgFUR1 gene with codons optimized for expression in E. coli was
cloned into an expression plasmid and subsequently expressed in E. coli
BL21. AgUPRT was initially produced as an insoluble protein at in-
duction temperatures of 37 and 18 °C (data not shown), but by N-
Fig. 4. Alignment of AgUPRT with other UPRTs and corresponding phylogenetic tree. (A) UPRT amino acid sequences from A. gossypii (Agos, NP_985599), K.
marxianus (Kmar, XP_022674246), S. cerevisiae (Scer, NP_011996), Y. lipolytica (Ylip, XP_506088), D. hansenii (Dhan, XP_002770455), P. guilliermondii (Pgui,
XP_001482408), L. donovani (Ldon, XP_003864273) and T. gondii (Tgon, XP_002364470). Four conserved regions from human to prokaryotes are shaded in grey
[22]. The residues that constitute a β-arm, a flex-loop and the PRPP and uracil binding sites identified previously [23] are marked with black lines. Boxed residues
represent positions where mutations were reported to increase resistance to 5-Flucytosine or 5-Fluorouracil. Asterisks (*) represent fully conserved residues, colons (:)
represent residues with strongly similar properties and periods (.) represent residues with weakly similar properties. (B) Phylogenetic tree resultant from the
alignment performed by ClustalO, which was drawn with FigTree v1.4.3. Indicated values represent the percentage of sequence identity to AgUPRT.
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terminal fusion to TrxA it was subsequently expressed mostly in soluble
form (Fig. 5). Over 2mg of purified TrxA-AgUPRT fusion protein was
obtained per 20mL of bacterial culture induced at 18 °C with IPTG.
AgUPRT was then cleaved efficiently from TrxA with TEV protease and
further purified (Fig. 5), with an overall yield of 0.3 mg of pure AgUPRT
per mg of fusion protein. The cleaved and purified AgUPRT could be
observed in SDS-PAGE gel as a single band of ˜26 kDa, consistent with
its calculated molecular weight (Fig. 5), and was stable when stored at
4 °C in Tris-NaCl buffer for at least 1 week.
AgUPRT activity is negatively affected by high uracil concentrations
The purified recombinant AgUPRT was enzymatically active, cata-
lyzing the phosphoribosylation of uracil to UMP in the presence of
PRPP (Fig. 6). Maximum activity was obtained with 0.4-0.5mM uracil
in the presence of 1mM PRPP, decreasing thereafter with increasing
uracil concentrations (Fig. 6A). On the other hand, activity in the pre-
sence of 0.5 mM uracil and at varying concentrations of PRPP was
maximal at 0.75–1mM PRPP, remaining constant thereafter (Fig. 6B).
As shown in Fig. 7, uracil concentrations ≥1mM negatively affected
AgUPRT activity in a statistically significant way, such that with
1.25mM uracil, catalytic activity was approximately 80% of maximum.
This dose-dependent effect of uracil on AgUPRT activity could not be
circumvented by the addition of more PRPP (data not shown). These
observations are in line with what was observed in terms of growth of
the A. gossypii Agura3 mutant, for which uracil concentrations above
1mM were increasingly deleterious (Table 1; Fig. 2).
UPRT is an enzyme that is highly conserved across species [26] and
has been characterized in several organisms, from prokaryotes [27] to
humans [22]. Among them, the UPRTs from the protozoan parasites L.
donovani and T. gondii have also been described to be negatively af-
fected by high uracil concentration [14]. Moreover, the growth of an L.
donovani pyrimidine auxotroph was shown to be (i) inhibited by in-
creasing concentrations of uracil, (ii) not completely rescued by cyto-
sine, and (iii) only fully restored when uridine was used as supple-
mentation [13], thus revealing a surprising, but also striking similarity
to what was observed here with A. gossypii Agura3.
The conversion of uracil to UMP catalyzed by UPRT is dependent on
the presence of PRPP, an essential precursor shared by the purine and
pyrimidine pathways, both de novo and salvage pathways [28,29]. In
turn, the purine biosynthetic pathway is essential for the production of
guanosine-5-triphosphate (GTP), one of the precursors for riboflavin
production. Indeed, a direct correlation between increased availability
of PRPP and riboflavin overproduction by A. gossypii was previously
demonstrated [30], which may explain the riboflavin-overproducing
phenotype displayed by the Agura3 mutant [11]. Overproduction of
riboflavin is a key differentiating trait of A. gossypii, not only at the
biotechnological level [9] but also ecologically, as it has been suggested
that A. gossypii overproduces riboflavin as a detoxifying [31,32] and
protective mechanism [33]. Although the regulatory mechanisms in-
volved in riboflavin overproduction remain largely unknown, the bio-
logical relevance of the negative regulation of AgUPRT activity by high
uracil concentration is most likely related with this trait, for which it
Fig. 5. SDS-PAGE analyses of the production (A) and purification (B) of
AgUPRT from E. coli. Lane 1, crude extract of cells producing AgUPRT fusion
with TrxA (TrxA-AgUPRT); Lanes 2, molecular weight markers; Lane 3, su-
pernatant containing the soluble protein fraction after lysis of the TrxA-AgUPRT
producing cells; Lane 4, AgUPRT cleaved and purified from TrxA-AgUPRT.
Fig. 6. AgUPRT activity at varying concentrations of uracil and PRPP. Specific AgUPRT activity was determined spectrophotometrically as a function of uracil
concentration in the presence of 1mM PRPP (A), and as a function of PRPP concentration in the presence of 0.5mM uracil concentration (B). Data represent
average ± standard deviation from three experimental replicates.
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may well contribute as a mechanism to preserve PRPP for purine (and
ultimately riboflavin) biosynthesis. Apart from ATP, which is present at
mM levels, the average physiological concentrations of purines and
pyrimidines for the routine functioning of the cell are in the μM range
[34]. Therefore, after these requirements are satisfied, PRPP can be
channeled for the generation of precursors (GTP) for the production of
riboflavin, which in A. gossypii is highly active in the late stages of
growth and can easily reach very high concentrations (up to 20 g L−1)
[35,36].
Evidence supporting this hypothesis can be found in the almost
perfect parallel with the events in L. donovani and T. gondii. Since
protozoan parasites lack the de novo purine biosynthetic pathway, they
must scavenge nutritionally essential purines from their hosts [13],
which they do through the purine salvage pathway, activity of which
relies on two other PRPP-dependent enzymes. Therefore, the biological
relevance for the presence in these parasites of a uracil-mediated reg-
ulation mechanism of UPRT has been linked with the increased need of
PRPP for purine biosynthesis [14]. Although the PRPP needs of each
organism are for different purposes, the fact that A. gossypii, L. donovani
and T. gondii have UPRTs which, after reaching a maximum activity, are
negatively affected by increasing uracil concentrations strongly in-
dicates that this mechanism may exist to favor purine synthesis when
the pyrimidine requirements are satisfied.
A further independent and remarkable support to this hypothesis is
the fact that uracil auxotrophs from other highly flavinogenic fungi,
such as the yeasts P. guilliermondii and D. hansenii, are also unable to
grow well in medium supplemented with uracil alone [5,6]. These re-
ports indicate that the hypersensitivity to uracil observed in A. gossypii
Agura3 extends to pyrimidine auxotrophs of other flavinogenic fungi
and suggest that the UPRT modulation mechanism also exists in these
fungi, just as the phenotypes and corresponding molecular mechanisms
observed in L. donovani extend to other protozoan parasites (e.g., T.
gondii) [14].
Conclusions
Here, it is shown that high uracil concentrations negatively affect
AgUPRT activity, which can explain the growth impairment observed in
the A. gossypii Agura3 auxotroph when increasing concentrations of this
pyrimidine intermediate are present in the medium. Until now, this
phenomenon had been only reported to exist in protozoan parasites.
The present findings demonstrate that this type of mechanism exists
beyond the requirement for survival and can be extended to micro-
organisms that are phylogenetically distant from parasites. Moreover,
since uracil auxotrophs are regularly used as backgrounds in genetic
and metabolic engineering strategies, awareness is raised to these
unusual phenotypes that may interfere with the correct assessment of
strain modification outcomes.
From a biotechnological point of view, understanding the mechan-
isms behind the biosynthesis of high-value products by natural micro-
bial producers is essential to develop stable and long-lasting bio-
technological processes. After years of improving riboflavin production
yields and titers in A. gossypii, the unraveling of new regulatory me-
chanisms involved in its biosynthesis will ensure the maintenance of
this paradigm process in the successful industrial track. Contributing to
that, the modulation mechanism of the AgUPRT activity reported here
reveals a new way of economizing essential metabolic precursors for
riboflavin overproduction by A. gossypii.
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